Catalyst Wire Dossier Catalyst Wire Dossier

Presendin

· Invex Therapeutics Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Presendin, covering 2024-04-24 to 2024-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Determine the Efficacy and Safety of Presendin in IIH [Phase 3]

See pricing